These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 8234410

  • 1. Interaction of tacrine at M1 and M2 cholinoceptors in guinea pig brain.
    Szilagyi M, Lau WM.
    Pharmacology; 1993 Oct; 47(4):223-9. PubMed ID: 8234410
    [Abstract] [Full Text] [Related]

  • 2. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD, Mash DC.
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [Abstract] [Full Text] [Related]

  • 3. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C, Andresen I, Lambrecht G, Mohr K.
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [Abstract] [Full Text] [Related]

  • 4. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT, Ferrendelli CA, Hanchett HE, Hollifield MA, Lorenzi MV.
    Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
    [Abstract] [Full Text] [Related]

  • 5. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 6. Allosteric effects of the alkane-bis-ammonium compound W84 and of tacrine on [3H]pirenzepine binding at M1-receptors in rat cerebral cortex.
    Mohr K, Tränkle C.
    Pharmacol Toxicol; 1994 Dec; 75(6):391-4. PubMed ID: 7899262
    [Abstract] [Full Text] [Related]

  • 7. AF-DX 116 discriminates heart from gland M2-cholinoceptors in man.
    Pitschner HF, Schulte B, Schlepper M, Palm D, Wellstein A.
    Life Sci; 1989 Dec; 45(6):493-8. PubMed ID: 2770414
    [Abstract] [Full Text] [Related]

  • 8. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 9. Quantitative autoradiographic localization of the M1 and M2 subtypes of muscarinic acetylcholine receptors in the monkey brain.
    Miyoshi R, Kito S, Shimoyama M.
    Jpn J Pharmacol; 1989 Oct; 51(2):247-55. PubMed ID: 2593382
    [Abstract] [Full Text] [Related]

  • 10. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
    Aubert I, Cécyre D, Gauthier S, Quirion R.
    Eur J Pharmacol; 1992 Jul 07; 217(2-3):173-84. PubMed ID: 1425938
    [Abstract] [Full Text] [Related]

  • 11. A pharmacological profile of glycopyrrolate: interactions at the muscarinic acetylcholine receptor.
    Lau WM, Szilagyi M.
    Gen Pharmacol; 1992 Nov 07; 23(6):1165-70. PubMed ID: 1283139
    [Abstract] [Full Text] [Related]

  • 12. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD, Annis SJ, Ehlert FJ, Leslie FM.
    J Pharmacol Exp Ther; 1991 Mar 07; 256(3):1173-81. PubMed ID: 2005579
    [Abstract] [Full Text] [Related]

  • 13. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 07; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 14. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
    Giraldo E, Micheletti R, Montagna E, Giachetti A, Viganò MA, Ladinsky H, Melchiorre C.
    J Pharmacol Exp Ther; 1988 Mar 07; 244(3):1016-20. PubMed ID: 3252019
    [Abstract] [Full Text] [Related]

  • 15. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 07; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 16. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites.
    Araujo DM, Lapchak PA, Regenold W, Quirion R.
    Synapse; 1989 Jul 07; 4(2):106-14. PubMed ID: 2781463
    [Abstract] [Full Text] [Related]

  • 17. Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine.
    Giraldo E, Hammer R, Ladinsky H.
    Life Sci; 1987 Mar 02; 40(9):833-40. PubMed ID: 3821380
    [Abstract] [Full Text] [Related]

  • 18. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M, Tastenoy M, Camus J, Christophe J.
    Mol Pharmacol; 1990 Aug 02; 38(2):267-73. PubMed ID: 2385234
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic M2 receptors in rat brain labeled with [3H] AF-DX 384.
    Castoldi AF, Fitzgerald B, Manzo L, Tonini M, Costa LG.
    Res Commun Chem Pathol Pharmacol; 1991 Dec 02; 74(3):371-4. PubMed ID: 1775727
    [Abstract] [Full Text] [Related]

  • 20. Quantitative autoradiographic distribution of [3H]AF-DX 116 muscarinic-M2 receptor binding sites in rat brain.
    Regenold W, Araujo DM, Quirion R.
    Synapse; 1989 Dec 02; 4(2):115-25. PubMed ID: 2781464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.